Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2014

Open Access 01-12-2014 | Research article

Biofilm formation of Clostridium difficile and susceptibility to Manuka Honey

Authors: Eric N Hammond, Eric S Donkor, Charles A Brown

Published in: BMC Complementary Medicine and Therapies | Issue 1/2014

Login to get access

Abstract

Background

Biofilm bacteria are relatively more resistant to antibiotics. The escalating trend of antibiotic resistance higlights the need for evaluating alternative potential therapeutic agents with antibacterial properties. The use of honey for treating microbial infections dates back to ancient times, though antimicrobial properties of Manuka honey was discovered recently. The aim of this study was to demonstrate biofilm formation of specific Clostridium difficile strains and evaluate susceptibility of the biofilm to Manuka honey.

Methods

Three C. difficile strains were used in the study including the ATCC 9689 strain, a ribotype 027 strain and a ribotype 106 strain. Each test strain was grown in sterile microtitre plates and incubated at 37°C for 24 and 48 hours in an anaerobic cabinet to allow formation of adherent growth (biofilm) on the walls of the wells. The effect of Manuka honey on the biofilms formed was investigated at varying concentrations of 1-50% (w/v) of Manuka honey.

Results

The three C. difficile strains tested formed biofilms after 24 hours with the ribotype 027 strain producing the most extensive growth. There was no significant difference (p > 0.05) found between the amount of biofilms formed after 24 and 48 hours of incubation for each of the three C. difficile strains. A dose–response relationship between concentration of Manuka honey and biofilm formation was observed for all the test strains, and the optimum Manuka honey activity occurred at 40-50% (v/v).

Conclusion

Manuka honey has antibacterial properties capable of inhibiting in vitro biofilm formed by C. difficile.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wolcott R, Cutting KF, Dowd SE: Surgical site infections: biofilms, dehiscence and delayed healing. Wound UK. 2008, 4 (4): 110-112. Wolcott R, Cutting KF, Dowd SE: Surgical site infections: biofilms, dehiscence and delayed healing. Wound UK. 2008, 4 (4): 110-112.
3.
go back to reference Rosenthal VD: Device-associated nosocomial infections in limited-resources countries: Findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2008, 36 (10): 171.e7-12.CrossRef Rosenthal VD: Device-associated nosocomial infections in limited-resources countries: Findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2008, 36 (10): 171.e7-12.CrossRef
4.
go back to reference Denkhaus E, Meisen S, Telgheder U, Wingender J: Chemical and physical methods for characterisation of biofilms. Microchimica Acta. 2007, 158 (1–2): 1-27.CrossRef Denkhaus E, Meisen S, Telgheder U, Wingender J: Chemical and physical methods for characterisation of biofilms. Microchimica Acta. 2007, 158 (1–2): 1-27.CrossRef
5.
go back to reference Cooper RA, Jenkins L: The inhibition of biofilms of Pseudomonas aeruginosa with Manuka honey. Ostomy Wound Manage. 2008, 54 (4): 70- Cooper RA, Jenkins L: The inhibition of biofilms of Pseudomonas aeruginosa with Manuka honey. Ostomy Wound Manage. 2008, 54 (4): 70-
6.
go back to reference Oliveria M, Numes SF, Carneiro C, Bexiga R, Bernardo F, Vilela CL: Time course of biofilm formation by Staphylococcus aureus and Staphylococcus epididermidis mastitis isolates. Vet Microbiol. 2007, 124 (1–2): 187-191.CrossRef Oliveria M, Numes SF, Carneiro C, Bexiga R, Bernardo F, Vilela CL: Time course of biofilm formation by Staphylococcus aureus and Staphylococcus epididermidis mastitis isolates. Vet Microbiol. 2007, 124 (1–2): 187-191.CrossRef
7.
go back to reference Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW: Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A. PLoS One. 2012, 7 (12): e50527-10.1371/journal.pone.0050527.CrossRefPubMedPubMedCentral Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW: Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A. PLoS One. 2012, 7 (12): e50527-10.1371/journal.pone.0050527.CrossRefPubMedPubMedCentral
8.
go back to reference Dapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M: Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol. 2013, 195 (3): 545-555. 10.1128/JB.01980-12.CrossRefPubMed Dapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M: Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol. 2013, 195 (3): 545-555. 10.1128/JB.01980-12.CrossRefPubMed
9.
go back to reference Donelli G, Vuotto C, Cardines R, Mastrantonio P: Biofilm-growing intestinal anaerobic bacteria. FEMS Immunol Med Microbiol. 2012, 65 (2): 318-325. 10.1111/j.1574-695X.2012.00962.x.CrossRefPubMed Donelli G, Vuotto C, Cardines R, Mastrantonio P: Biofilm-growing intestinal anaerobic bacteria. FEMS Immunol Med Microbiol. 2012, 65 (2): 318-325. 10.1111/j.1574-695X.2012.00962.x.CrossRefPubMed
11.
go back to reference Semenyuk EG, Laning ML, Foley J, Johnston PF, Knight KL, Gerding DN, Driks A: Spore formation and toxin production in Clostridium difficile biofilms. PLoS One. 2014, 9 (1): e87757-10.1371/journal.pone.0087757.CrossRefPubMedPubMedCentral Semenyuk EG, Laning ML, Foley J, Johnston PF, Knight KL, Gerding DN, Driks A: Spore formation and toxin production in Clostridium difficile biofilms. PLoS One. 2014, 9 (1): e87757-10.1371/journal.pone.0087757.CrossRefPubMedPubMedCentral
12.
go back to reference Crowther GS, Chilton CH, Todhunter SL, Nicholson S, Freeman J, Baines SD, Wilcox MH: Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of clostridium difficile and human microbiota. PLoS One. 2014, 9 (2): e88396-10.1371/journal.pone.0088396.CrossRefPubMedPubMedCentral Crowther GS, Chilton CH, Todhunter SL, Nicholson S, Freeman J, Baines SD, Wilcox MH: Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of clostridium difficile and human microbiota. PLoS One. 2014, 9 (2): e88396-10.1371/journal.pone.0088396.CrossRefPubMedPubMedCentral
13.
go back to reference Lembke C, Podbielsk A, Hidalgo-Grass C, Jona L, Hanski E, Kreikemeyer B: Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol. 2006, 72: 2864-2875. 10.1128/AEM.72.4.2864-2875.2006.CrossRefPubMedPubMedCentral Lembke C, Podbielsk A, Hidalgo-Grass C, Jona L, Hanski E, Kreikemeyer B: Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol. 2006, 72: 2864-2875. 10.1128/AEM.72.4.2864-2875.2006.CrossRefPubMedPubMedCentral
14.
go back to reference Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jorgensen A, Molin S, Tolker-Nielsen T: Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol. 2003, 48: 1511-1524. 10.1046/j.1365-2958.2003.03525.x.CrossRefPubMed Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jorgensen A, Molin S, Tolker-Nielsen T: Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol. 2003, 48: 1511-1524. 10.1046/j.1365-2958.2003.03525.x.CrossRefPubMed
15.
go back to reference Hancock LE, Perego M: The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J Bacteriol. 2004, 186: 5629-5639. 10.1128/JB.186.17.5629-5639.2004.CrossRefPubMedPubMedCentral Hancock LE, Perego M: The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J Bacteriol. 2004, 186: 5629-5639. 10.1128/JB.186.17.5629-5639.2004.CrossRefPubMedPubMedCentral
16.
go back to reference Cvitkovitch DG, Li YH, Ellen RP: Quorum sensing and biofilm formation in streptococcal infections. J Clin Investig. 2003, 112: 1626-1632. 10.1172/JCI200320430.CrossRefPubMedPubMedCentral Cvitkovitch DG, Li YH, Ellen RP: Quorum sensing and biofilm formation in streptococcal infections. J Clin Investig. 2003, 112: 1626-1632. 10.1172/JCI200320430.CrossRefPubMedPubMedCentral
17.
go back to reference Maddocks SE, Lopez MS, Rowlands RS, Cooper RA: Manuka honey inhibits the development of Streptococcus pyogenes biofilms and causes reduced expression of two fibronectin binding proteins. Microbiology. 2012, 158: 781-790. 10.1099/mic.0.053959-0.CrossRefPubMed Maddocks SE, Lopez MS, Rowlands RS, Cooper RA: Manuka honey inhibits the development of Streptococcus pyogenes biofilms and causes reduced expression of two fibronectin binding proteins. Microbiology. 2012, 158: 781-790. 10.1099/mic.0.053959-0.CrossRefPubMed
18.
go back to reference Rodica G, Bruno H, Elise F, Colette G, Marc D: Epidemiology patterns and hospital characteristics associated with increased incident of Clostridium difficile infection in Qubec, Canada, 1998–2006. Infect Control Hosp Epidemiol. 2010, 31 (9): 939-947. 10.1086/655463.CrossRef Rodica G, Bruno H, Elise F, Colette G, Marc D: Epidemiology patterns and hospital characteristics associated with increased incident of Clostridium difficile infection in Qubec, Canada, 1998–2006. Infect Control Hosp Epidemiol. 2010, 31 (9): 939-947. 10.1086/655463.CrossRef
19.
go back to reference Barbut F, Jones G, Eckert C: Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis. 2011, 24 (4): 370-376. 10.1097/QCO.0b013e32834748e5.CrossRefPubMed Barbut F, Jones G, Eckert C: Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis. 2011, 24 (4): 370-376. 10.1097/QCO.0b013e32834748e5.CrossRefPubMed
22.
go back to reference Answar H, Dasgupta MK, Costerton JW: Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother. 1990, 34 (11): 2043-2046. 10.1128/AAC.34.11.2043.CrossRef Answar H, Dasgupta MK, Costerton JW: Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother. 1990, 34 (11): 2043-2046. 10.1128/AAC.34.11.2043.CrossRef
23.
go back to reference Consterton JW: Overview of microbial biofilms. J Indus Microbial. 1995, 15: 137-140. 10.1007/BF01569816.CrossRef Consterton JW: Overview of microbial biofilms. J Indus Microbial. 1995, 15: 137-140. 10.1007/BF01569816.CrossRef
24.
go back to reference Danese PN, Pratt LA, Kolter R: Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol. 2000, 182 (12): 3593-3596. 10.1128/JB.182.12.3593-3596.2000.CrossRefPubMedPubMedCentral Danese PN, Pratt LA, Kolter R: Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol. 2000, 182 (12): 3593-3596. 10.1128/JB.182.12.3593-3596.2000.CrossRefPubMedPubMedCentral
25.
go back to reference Freeman J, Bauer MP, Baines SD, J. Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH: The Changing Epidemiology of Clostridium difficile Infections. Clin. Microbiol. Rev. 2010, 23 (3): 529-549. 10.1128/CMR.00082-09.CrossRefPubMedPubMedCentral Freeman J, Bauer MP, Baines SD, J. Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH: The Changing Epidemiology of Clostridium difficile Infections. Clin. Microbiol. Rev. 2010, 23 (3): 529-549. 10.1128/CMR.00082-09.CrossRefPubMedPubMedCentral
26.
go back to reference Okhiria OA, Henriques AFM, Burton NF: Honey modulates biofilms of Pseudomonas aeruginosa in a time and dose dependent manner. J ApiProd ApiMed Sci. 2009, 1: 6-10. 10.3896/IBRA.4.01.1.03.CrossRef Okhiria OA, Henriques AFM, Burton NF: Honey modulates biofilms of Pseudomonas aeruginosa in a time and dose dependent manner. J ApiProd ApiMed Sci. 2009, 1: 6-10. 10.3896/IBRA.4.01.1.03.CrossRef
27.
go back to reference Fux CA, Consterton JW, Stewart PS, Stoodley P: Survival strategies of infectious biofilms. Trends Microbiol. 2005, 13 (1): 34-40. 10.1016/j.tim.2004.11.010.CrossRefPubMed Fux CA, Consterton JW, Stewart PS, Stoodley P: Survival strategies of infectious biofilms. Trends Microbiol. 2005, 13 (1): 34-40. 10.1016/j.tim.2004.11.010.CrossRefPubMed
28.
go back to reference Ashby MJ, Neale JE, Knott SJ, Critchley IA: Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. J Antimicrob Chemother. 1994, 33: 443-452. 10.1093/jac/33.3.443.CrossRefPubMed Ashby MJ, Neale JE, Knott SJ, Critchley IA: Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. J Antimicrob Chemother. 1994, 33: 443-452. 10.1093/jac/33.3.443.CrossRefPubMed
29.
go back to reference Consterton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infection. Science. 1999, 284: 1318-1322. 10.1126/science.284.5418.1318.CrossRef Consterton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infection. Science. 1999, 284: 1318-1322. 10.1126/science.284.5418.1318.CrossRef
30.
go back to reference Alandejani T, Marsan JG, Ferris W, Slinger R, Chan F: Effectiveness of honey on S. aureus and P. aeruginosa biofilms. Otolaryngol Head Neck Surg. 2008, 14 (1): 114-118. Alandejani T, Marsan JG, Ferris W, Slinger R, Chan F: Effectiveness of honey on S. aureus and P. aeruginosa biofilms. Otolaryngol Head Neck Surg. 2008, 14 (1): 114-118.
31.
go back to reference Ansari MJ, Al-Ghamdi A, Usmani S, Al-Waili NS, Sharma D, Nuru A, Al-Attal Y: Effect of jujube honey on Candida albicans growth and biofilm formation. Arch Med Res. 2013, 44 (5): 352-360. 10.1016/j.arcmed.2013.06.003.CrossRefPubMed Ansari MJ, Al-Ghamdi A, Usmani S, Al-Waili NS, Sharma D, Nuru A, Al-Attal Y: Effect of jujube honey on Candida albicans growth and biofilm formation. Arch Med Res. 2013, 44 (5): 352-360. 10.1016/j.arcmed.2013.06.003.CrossRefPubMed
32.
go back to reference Molan PC, Russell KM: Non-peroxide antibacterial activity in some New Zealand honeys. J Apic Res. 1988, 27 (1): 62-67.CrossRef Molan PC, Russell KM: Non-peroxide antibacterial activity in some New Zealand honeys. J Apic Res. 1988, 27 (1): 62-67.CrossRef
33.
go back to reference Atrott J, Haberlau S, Henle T: Studies on the formation of methylglyoxal from dihydroxyacetone in Manuka (Leptospermum scoparium) honey. Carbohydr Res. 2012, 361: 7-11.CrossRefPubMed Atrott J, Haberlau S, Henle T: Studies on the formation of methylglyoxal from dihydroxyacetone in Manuka (Leptospermum scoparium) honey. Carbohydr Res. 2012, 361: 7-11.CrossRefPubMed
34.
go back to reference Mavric E, Wittmann S, Barth G, Henle T: Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res. 2008, 52 (4): 483-489. 10.1002/mnfr.200700282.CrossRefPubMed Mavric E, Wittmann S, Barth G, Henle T: Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res. 2008, 52 (4): 483-489. 10.1002/mnfr.200700282.CrossRefPubMed
35.
go back to reference Mukherjee S, Chaki S, Das S, Sen S, Dutta SK, Dastidar SG: Distinct synergistic action of piperacillin and methylglyoxal against Pseudomonas aeruginosa. Indian J Exp Biol. 2011, 49: 547-551.PubMed Mukherjee S, Chaki S, Das S, Sen S, Dutta SK, Dastidar SG: Distinct synergistic action of piperacillin and methylglyoxal against Pseudomonas aeruginosa. Indian J Exp Biol. 2011, 49: 547-551.PubMed
Metadata
Title
Biofilm formation of Clostridium difficile and susceptibility to Manuka Honey
Authors
Eric N Hammond
Eric S Donkor
Charles A Brown
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2014
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-14-329

Other articles of this Issue 1/2014

BMC Complementary Medicine and Therapies 1/2014 Go to the issue